StocksRunner logo
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  Highlights  
 
  Updates  
 
 
 
Haemonetics Corporat
74.78
+1.06%
 

HAE

 

Haemonetics Corporat

$ 74.78

 
+$0.78 | +1.06%
 
 
Open
$ 74.18
 
 
MKT CAP
$ 3.80B
 
High
$ 74.98
 
 
VOL
$ 269.52K
 
Low
$ 73.68
 
 
AVG VOL
$ 0.52M
 
 
 

HAE Stock Analysis

  Login to display Haemonetics Corporat (HAE) recommendation from the last 90 days from financial news and social media.
 
 

HAE Total Score

 
 

Strengths

HAE Rewards

 Earnings are forecast to grow

HAE Rewards

 Upgraded on attractively valued

HAE Rewards

 Trading below its fair value

 
 

Chart

 
 

84.75

82.12

89.05

77.01

 
 
1month
3month
6month
1year
 

HAE Risk Level

This Indicator assigning HAE risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
HAE Risk Level
LOW
HIGH

Risk Volatility

 

HAE has Low Risk Level

Click here to check what is your level of risk

 

HAE Analysts Opinion

HAE overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information

 
 

Earnings

×
 

Earnings

3.60
 

HAE Earnings Sentiment

 Above analyst estimates

 
 

Rating

×
 

Rating

5.00
 

HAE Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

4.00
 
 

Activity

×
 

Activity

4.00
 
 

Future

×
 

Future

4.17
 

HAE Future Sentiment

 Earnings are forecast to grow

HAE Future Sentiment

 Trading below its fair value

 
 

HAE Analysts Opinion

HAE Analysts opinion is positive and also has improved from the past 3 months

 

HAE Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
94%
Buy
Opinion
Trend
Score
Potential
Score
 
 
100%
100%
100%
 
On Track
On Track
On Track
 

HAE Street Opinion 

HAE Street view is extremely ish and have positive views on the near-term outlook

 

HAE Performance Sentiment

Sentiments overview associated with HAE events and the stock performance.
 
94%
6%
Positive
Negative
15 out of 16
events present
1 out of 16
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

HAE Earnings

The TTM reflects 12-month period, providing review of HAE financial performance.

 
Millions of Dollars
TTM
2023
2022
CAGR
 

 
Total Revenue
1,270
1,169
993
+13.09%
 
 
Cost of Revenue
598
554
488
+10.70%
 
 
Gross Profit
672
615
506
+15.24%
 
 
Operating Exp
492
459
434
+6.47%
 
 
Operating Inc
180
156
71
+59.22%
 
 
Net Interest Inc
-9
-15
-17
-
 
 
Interest Exp
9
15
17
-27.24%
 
 
Other Income
-
10
-
 
 
EPS
2.53
2.27
0.85
+72.52%
 
 
Next Earnings Date: May 09, 2024
 
 
Highlights
Last Modify
Price
% Change

 
Investors Activity
1 Week Ago
73.29
+2.66%
 
Strong Earnings
3 Weeks Ago
74.20
-4.99%
 
Strong Earnings
3 Weeks Ago
78.11
+1.30%
 
Oversold
2 Month Ago
76.46
-4.72%
 
 
 
joker
 
 
 
StocksRunner

Explore our HAE Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored FDX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our HAE Daily Alerts

Access the exclusive insights that over 10,000+ subscribers value. Stay ahead in the stock market! Submit your email for daily alerts.

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo

StocksRunner

Get the pulse of the market

 
StocksRunner
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

HAE Rewards

 Earnings are forecast to grow

HAE Rewards

 Upgraded on attractively valued

HAE Rewards

 Trading below its fair value

 
 
 

HAE Risk Level

 
 
 

The Indicator assigning HAE risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
 
HAE Risk Level
LOW
HIGH

Risk Volatility

 

HAE has Low Risk Level. Click here to check what is your level of risk

 
 
 
 

Stock Analysis

 
 
 
 

HAE

 

Haemonetics Corporat

$ 74.78

 
+$0.78 | +1.06%
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  News  
 
  Updates  
 

 
joker
 
 
 
Open
$ 74.18
 
 
MKT CAP
$ 3.80B
 
High
$ 74.98
 
 
VOL
$ 269.52K
 
Low
$ 73.68
 
 
AVG VOL
$ 0.52M
 
 
 

HAE Analysis

  Sign in to view Haemonetics Corporat (HAE) recommendation from the last 90 days from financial news and social media.
 
 

Chart

 
 

84.75

82.12

89.05

77.01

 
 
1month
3month
6month
1year
 

HAE Analysts Opinion

HAE Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information

 
 

Earnings

×
 

Earnings

3.60
 

HAE Earnings Sentiment

 Above analyst estimates

 
 

Rating

×
 

Rating

5.00
 

HAE Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

4.00
 
 

Activity

×
 

Activity

4.00
 
 

Future

×
 

Future

4.17
 

HAE Future Sentiment

 Earnings are forecast to grow

HAE Future Sentiment

 Trading below its fair value

 
 

HAE Analysts Opinion

HAE Analysts opinion is positive and also has improved from the past 3 months

 

HAE Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
94%
Buy
Opinion
Trend
Score
Potential
Score
 
 
100%
100%
100%
 
On Track
On Track
On Track
 

HAE Street Opinion 

HAE Street view is extremely ish and have positive views on the near-term outlook

 
HAE Performance Sentiment
Sentiments overview associated with HAE events and the stock performance.
 
94%
6%
Positive
Negative
15 out of 16
events present
1 out of 16
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

HAE Earnings

The TTM data reflects the most recent 12-month period, providing overview of HAE financial performance.

 
Millions of Dollars
TTM
2023
2022
CAGR
 

 
Total Revenue
1,270
1,169
993
+13.09%
 
 
Cost of Revenue
598
554
488
+10.70%
 
 
Gross Profit
672
615
506
+15.24%
 
 
Operating Exp
492
459
434
+6.47%
 
 
Operating Inc
180
156
71
+59.22%
 
 
Net Interest Inc
-9
-15
-17
-
 
 
Interest Exp
9
15
17
-27.24%
 
 
Other Income
-
10
-
 
 
EPS
2.53
2.27
0.85
+72.52%
 
 
Next Earnings Date: May 09, 2024
 
Highlights
Last Modify
Price
% Change

 
Investors Activity
1 Week Ago
73.29
+2.66%
 
Strong Earnings
3 Weeks Ago
74.20
-4.99%
 
Strong Earnings
3 Weeks Ago
78.11
+1.30%
 
Oversold
2 Month Ago
76.46
-4.72%
 
 
HAE Latest News Feed

What Makes Haemonetics (HAE) a New Buy Stock. Haemonetics (HAE) appears an attractive pick as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of

Tue Feb 27, 2024

Momentum
Potential
Rating

Haemonetics to Present at Citis 2024 Unplugged Medtech and Life Sciences Access Day. BOSTON Feb. 21 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon President and CEO will participate in a fireside chat with investors at

Wed Feb 21, 2024

Activity

Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference. BOSTON Feb. 21 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon President and CEO will participate in a fireside chat with investors

Wed Feb 21, 2024

Activity

heres why haemonetics (hae) is a strong value stock. for new and old investors taking full advantage of the stock market and investing with confidence are common goals. zacks premium provides l

Fri Feb 9, 2024

Potential

haemonetics (hae) q3 earnings top estimates 2024 view raised. haemonetics corporation hae delivered adjusted earnings per share (eps) of $1.04 for the third quarter of fiscal 2024 up 22.4% year

Fri Feb 9, 2024

Earnings

haemonetics (hae) surpasses q3 earnings and revenue estimates. haemonetics (hae) came out with quarterly earnings of $1.04 per share beating the zacks consensus estimate of $0.97 per share. thi

Thu Feb 8, 2024

Earnings

haemonetics beats q3 top and bottom line estimates updates guidance.

Thu Feb 8, 2024

Earnings

haemonetics q3 profit down but beats estimates. lifts annual earnings outlook above view - update. (rttnews) - (adds outlook)

Thu Feb 8, 2024

Earnings
Earnings
Potential

oversold conditions for haemonetics (hae). legendary investor warren buffett advises to be fearful when others are greedy and be greedy when others are fearful. one way we can try to measure the level of fear in a given stock is through a t

Wed Jan 31, 2024

Momentum

why haemonetics (hae) is a top value stock for the long-term. it doesnt matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals f

Thu Jan 18, 2024

Potential

heres why haemonetics (hae) is a strong growth stock. it doesnt matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all i

Fri Jan 12, 2024

Potential

 
 
 
 
 

Score Tracker

 
 
 
Based on 16 events in the last 90 days from financial news and social media. Last updated Mar 4, 2024 16:31 Wall St. time
 
 

HAE Total Score

 
 
 
 
 
 
 
StocksRunner

Discover HAE Stock analysis and effective trading strategies with StocksRunner. Gain valuable insights into stock performance, market trends, and the future potential of HAE. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our HAE Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

HAE Stock trends

HAE Stock performance

HAE Stock analysis

HAE investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
Post ×
 
0/666
joker